Skip to content
Agentic OS
Menu

Intelligence / Logistics & supply chain market map / Cold-chain infrastructure and monitoring equipment / Cold-store systems and temperature-controlled storage equipment / Pharma manufacturers outsourcing temperature-controlled storage

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Pharma manufacturers outsourcing temperature-controlled storage

Pharmaceutical manufacturers and biologic, vaccine, gene-therapy and cell-therapy producers that need outsourced cold-store capacity, validated storage modules and monitored handling of temperature-sensitive products between manufacturing and patient delivery. Buyer job: maintain validated temperature control and documented chain-of-custody evidence under FDA 21 CFR Part 211, EU GMP Annex 15 and WHO GDP guidance. Trigger: growth in temperature-sensitive pharmaceutical volumes, new biologics or cell-therapy launches, and regulatory requirements for documented temperature maintenance. Distinct from cold-chain monitoring buyers because this niche is defined by outsourced storage capacity and va

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
80 /100
for B2B sellers
Evidence
not sized
2 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Pharmaceutical manufacturers and CDMOs
Buying centre
Quality assurance and regulatory affairs lead the specification and approval; supply chain and manufacturing operations own the budget; procurement runs sourcing; logistics and cold-storage operators can be contracted capacity suppliers. Decision criteria include validated temperature zones, calibra
Buying triggers
  • Expansion of temperature-sensitive pharmaceutical volumes, including biologics, vaccines, gene therapies and cell therapies
  • Entry of new biologics, vaccines or cell-therapy products requiring validated storage
  • Regulatory frameworks requiring documented evidence of maintained cold-chain conditions
  • Requirement for contingency capacity during supply disruptions or facility transitions
Pains
  • Risk of temperature excursions invalidating batches or clinical supply
  • Gaps in documented chain-of-custody evidence
  • Limited surge or backup capacity for launches and supply disruptions
  • Fragmented monitoring and record systems across storage, transport and quality workflows
Scores (1–5)
Pain intensity5
Purchasing power4
Reachability3
Growth4

How this was sized

Not sized yet

No source provides the supplier revenue attributable specifically to pharmaceutical cold-store systems. Proxy inputs: global cold-chain monitoring market was USD 9.07bn in 2025 [5], and monitoring is an adjacent segment rather than a direct measure of storage-system revenue. A defensible niche split cannot be derived without storage-capacity or end-use revenue shares, so no niche revenue is stated. Confidence in the absence of a published allocation is Low.

Alongside it in Cold-store systems and temperature-controlled storage equipment

// Sell into Pharma manufacturers outsourcing temperature-controlled storage

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.